|
|
||||||||
Technical Briefs |
1 Institute of Clinical Chemistry, University of Munich, Munich, Germany;
2 Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong SAR, China;
aaddress correspondence to this author at: University Hospital of Munich-Grosshadern, Institute of Clinical Chemistry, Marchioninistrasse 15, D-81377 Munich, Germany; fax 49-89-7095-6298, e-mail Stefan.Holdenrieder@.med.uni-muenchen.de
| The first 20% of the full text of this article appears below. |
Although circulating DNA has generally been referred to as cell-free DNA, it is likely that a significant proportion is bound to protein molecules, possibly as nucleosomes. This conclusion is supported by theory and by observations. Theoretically, circulating DNA is mostly released from degrading cells after cleavage by endonucleases that cut the chromatin into the basic nucleosomal elements (1)(2). Empirically, DNA fragments in circulation are mainly sized in multiples of the nucleosomal DNA (3)(4). Filtration experiments have shown that circulating RNA seems to be associated with particles, whereas DNA is not (5). This might be attributable to the arrangement of DNA in nucleosomes, which conserves them from proteolytic digestion in blood. Nucleosomal complexes consist of duplicate copies of the histones H2A, H2B, H3, and H4 as core proteins, with
146 bp of DNA on the outside (6).
In various pathologic conditions, qualitative and quantitative changes in circulating DNA have been shown. Only small amounts of serum or plasma DNA have been observed in healthy individuals, whereas high concentrations have been described in patients with various malignancies and in those with several benign diseases, such as infections, sepsis, trauma, stroke, and autoimmune diseases (3)(7)(8)(9)(10)(11)(12)(13). Because most of these disorders are associated
The following articles in journals at HighWire Press have cited this article:
![]() |
S. Holdenrieder, J. von Pawel, E. Dankelmann, T. Duell, B. Faderl, A. Markus, M. Siakavara, H. Wagner, K. Feldmann, H. Hoffmann, et al. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer Clin. Cancer Res., December 1, 2008; 14(23): 7813 - 7821. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Deligezer, E. E. Akisik, N. Erten, and N. Dalay Sequence-Specific Histone Methylation Is Detectable on Circulating Nucleosomes in Plasma Clin. Chem., July 1, 2008; 54(7): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Umetani, J. Kim, S. Hiramatsu, H. A. Reber, O. J. Hines, A. J. Bilchik, and D. S. B. Hoon Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU Repeats. Clin. Chem., June 1, 2006; 52(6): 1062 - 1069. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |